Press Releases Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program January 14, 2025 Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population January 7, 2025 Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial January 26, 2023 No-implant interatrial shunt device to treat heart failure patients reveals promising multi-center clinical data May 20, 2022 Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences May 17, 2021 Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology January 25, 2021